How to Sell a Food and Beverage Manufacturing Business: 5-8x EBITDA, SQF/BRC Compliance, and Named PE Platforms (2026)

Food and beverage manufacturing M&A in 2026 is more complex than general industrial M&A. Food safety compliance (FDA, FSMA, SQF, BRC, HACCP), customer co-manufacturing relationships with major CPG brands, shelf-life and inventory economics, supplier traceability requirements, and recall liability all interact in ways that buyers underwrite carefully. EBITDA multiples of 5-8x reflect the category complexity plus stable end-market demand.

This guide is for owners of F&B manufacturers with $1M-$50M of EBITDA evaluating a sale or recap. We’ll walk through realistic multiples by category (specialty/better-for-you, co-manufacturer, private label, commodity), the named buyers actively acquiring (Wind Point Partners, Arsenal Capital Partners, Atlas Holdings, plus CPG strategics like P&G, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez), the specific compliance requirements buyers diligence, and the preparation steps that materially shift outcome.

The framework draws on direct work with 76+ active U.S. lower middle market buyers including 38 manufacturing-focused capital partners. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes F&B-focused PE platforms (Wind Point Partners, Arsenal Capital Partners), industrial PE with F&B experience (Atlas Holdings, KPS Capital Partners), CPG strategic acquirers (Procter & Gamble, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez International, Unilever, Nestlé USA, Conagra Brands, Campbell Soup, Hormel Foods, Tyson Foods), and family offices targeting F&B sector exposure.

One realistic note before you start. The 5-8x range applies to FDA-registered, SQF/BRC-certified manufacturers with traceable supply chains and verifiable food safety records. Businesses operating without proper certifications, with recall history, or with traceability gaps trade closer to general industrial multiples (4-6x EBITDA) or face deal-killing diligence findings. Compliance status is the gating differentiator.

“F&B manufacturing M&A is more complex than general industrial because food safety compliance, customer co-manufacturing relationships, and shelf-life economics interact in ways that buyers underwrite carefully. The owners who realize 7-8x EBITDA are the ones who built SQF Level 3 or BRC AA-rated certifications, embedded co-manufacturing relationships with named CPG brands, and went to market through buy-side partners with F&B-specific buyer relationships. The right answer is a buy-side partner who already knows the F&B buyers, not a broker selling them a process.”

Key Takeaways

• F&B manufacturing multiples by category: specialty/better-for-you 7-8x; co-manufacturers for CPG 5.5-7x; private label 5-6.5x; commodity 4.5-6x.
• Active buyers: Wind Point Partners, Arsenal Capital Partners, Atlas Holdings, KPS Capital Partners, plus CPG strategics P&G (NYSE: PG), PepsiCo (NASDAQ: PEP), Coca-Cola (NYSE: KO), Kraft Heinz (NASDAQ: KHC), General Mills (NYSE: GIS), Mondelez (NASDAQ: MDLZ).
• SQF Level 2 (manufacturing) or Level 3 (manufacturing with quality management) certification is the most common food safety standard. BRC Global Standard is an alternative; both required by major CPG customers.
• FDA registration mandatory. FSMA (Food Safety Modernization Act) preventive controls implementation including Food Safety Plans, Hazard Analysis, Foreign Supplier Verification Programs (FSVP) for imported ingredients.
• Customer concentration with named CPG brands typically discounted moderately given relationship stickiness. Single-customer above 50% triggers customer-retention earnout structures.
• Recall history and food safety incident records are gating diligence. Class I recalls (severe health hazard) significantly affect valuation; Class II/III recalls less so if remediated.

Why F&B manufacturers trade at 5-8x EBITDA

Food and beverage manufacturing EBITDA multiples reflect a balance of stable end-market demand and category-specific complexity. Stable demand: food consumption is recession-resistant, US population growth supports baseline demand growth, and CPG manufacturers maintain consistent capex cycles. Category complexity: food safety compliance burden, recall liability exposure, customer co-manufacturing relationship stickiness, shelf-life economics, and ingredient cost pass-through all complicate buyer underwriting.

What drives the top of the 5-8x range. Specialty and better-for-you positioning (organic, plant-based, functional, free-from). Embedded co-manufacturing relationships with named CPG brands. SQF Level 3 or BRC AA-rated certifications. No customer concentration above 30%. Strong gross margins (25%+ for finished goods manufacturers). EBITDA growth above 8% per year. Multi-state distribution capability. No recall history.

What drives the bottom of the 5-8x range. Commodity category positioning (mainstream packaged goods, ingredients). Single-customer concentration above 50%. SQF Level 2 only or no third-party certification. Recall history (especially Class I). Margin compression from ingredient cost increases without pass-through. Single-state distribution. Aging facility with deferred capex.

Premium and discount factors that shift positioning within range. Premium drivers (each adds 0.25-0.5x EBITDA): SQF Level 3 certification, BRC AA rating, organic/non-GMO certifications, allergen-free certifications, kosher/halal certifications, multi-customer F500 CPG relationships, vertical integration (own-brand portfolio plus co-manufacturing), real estate ownership. Discount drivers (each subtracts 0.25-1x): single-customer concentration above 50%, recall history, regulatory enforcement actions, food safety inspection findings, supplier concentration, ingredient pass-through limitations.

Category multiples: specialty vs co-man vs private label vs commodity

Within F&B manufacturing, multiples vary 2-3x EBITDA by category positioning. Specialty and better-for-you brands at the top. Co-manufacturers for major CPG brands in the upper-middle. Private label manufacturers in the middle. Commodity food and beverage at the bottom. Direct-to-consumer brands have wide variance depending on customer acquisition cost economics.

Specialty and better-for-you brands: 7-8x EBITDA. Branded products in growth categories: organic, plant-based, functional foods, clean-label, free-from (gluten-free, dairy-free, sugar-free), keto/paleo, ethnic foods (Hispanic, Asian-fusion). End-markets: natural channel (Whole Foods, Sprouts, Fresh Market), club channel (Costco, Sam’s Club, BJ’s), conventional grocery (Kroger, Publix, Albertsons). Active buyers: Arsenal Capital Partners, Wind Point Partners, plus CPG strategics for tuck-in brand acquisitions. Multiples can reach 8-10x for category-leading brands with strong unit economics.

Co-manufacturers for major CPG brands: 5.5-7x EBITDA. Companies that manufacture branded products on behalf of major CPG companies (Procter & Gamble, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez, Unilever, Nestlé, Conagra, Campbell Soup, Hormel, Tyson). End-markets: CPG supply chain. Multiples reflect customer relationship stickiness (multi-year co-manufacturing agreements) and operational scale requirements. Active buyers: F&B-focused PE platforms, industrial PE with F&B experience.

Private label manufacturers: 5-6.5x EBITDA. Companies manufacturing private label products for Costco (Kirkland), Walmart (Great Value, Sam’s Choice), Kroger (Simple Truth, Private Selection), Target (Good & Gather, Favorite Day), Albertsons, Aldi. Multiples reflect price-competitive market dynamics balanced by retailer relationship stickiness. Active buyers: F&B-focused PE, retail-supply consolidators.

Commodity food and beverage: 4.5-6x EBITDA. Mainstream packaged goods, commodity ingredients, basic beverages without brand differentiation. Lower multiples reflect competitive pressure, limited pricing power, and ingredient cost exposure. Multiples improve with operational excellence, large scale, and customer relationship depth. Active buyers: industrial PE platforms, strategic consolidators.

F&B category	Multiple range	Top customers	Active buyers
Specialty / better-for-you	7-8x EBITDA	Whole Foods, Costco, Kroger, DTC	Arsenal Capital, Wind Point, CPG strategics
Co-manufacturers for CPG	5.5-7x EBITDA	P&G, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez	F&B PE, industrial PE with F&B experience
Private label manufacturers	5-6.5x EBITDA	Costco, Walmart, Kroger, Target, Aldi	F&B PE, retail-supply consolidators
Commodity food and beverage	4.5-6x EBITDA	Multi-channel commodity sales	Industrial PE, strategic consolidators
Direct-to-consumer brands	4-7x EBITDA (high variance)	Online direct sales	Consumer PE, growth equity, family offices

Who actually buys food and beverage manufacturing businesses in 2026

The 2026 F&B manufacturing buyer pool divides into four archetypes with different deal economics. Knowing which archetype fits your business shapes everything: positioning, marketing materials, deal structure, and realistic price expectation.

Archetype 1: F&B-focused PE platforms. Wind Point Partners (consumer and industrial focus including F&B). Arsenal Capital Partners (specialty manufacturing including F&B). Atlas Holdings (industrial conglomerate with F&B platforms). KPS Capital Partners (industrial including F&B). Centre Lane Partners (specialty consumer). Multiples: 6-8x EBITDA with rollover equity opportunity. Best fit: $5-50M EBITDA F&B manufacturers with growth thesis or platform fit.

Archetype 2: CPG strategic acquirers. Procter & Gamble (NYSE: PG), PepsiCo (NASDAQ: PEP), Coca-Cola (NYSE: KO), Kraft Heinz (NASDAQ: KHC), General Mills (NYSE: GIS), Mondelez International (NASDAQ: MDLZ), Unilever (NYSE: UL), Nestlé USA (subsidiary of OTC: NSRGY), Conagra Brands (NYSE: CAG), Campbell Soup (NYSE: CPB), Hormel Foods (NYSE: HRL), Tyson Foods (NYSE: TSN), Smucker (NYSE: SJM). Multiples: 7-12x EBITDA for strategic acquisitions, often premium pricing for emerging brands or capability-extension acquisitions.

Archetype 3: Industrial PE platforms with F&B experience. Audax Group (multiple F&B platforms historically). Sun Capital Partners (consumer/F&B focus). H.I.G. Capital. Wynnchurch Capital. Multiples: 5.5-7.5x EBITDA. Best fit: $3-25M EBITDA F&B manufacturers that fit broader industrial portfolio thesis.

Archetype 4: Consumer PE and growth equity. L Catterton (consumer focus including F&B). VMG Partners (consumer products). General Atlantic. TSG Consumer Partners. North Castle Partners. Multiples: 6-9x EBITDA, often premium pricing for growth brands with strong unit economics. Best fit: branded F&B businesses with growth trajectory and category-leading positioning.

Buyer type	Cash at close	Rollover equity	Exclusivity	Best fit for
Strategic acquirer	High (40–60%+)	Low (0–10%)	60–90 days	Sellers who want a clean exit; competitor or upstream consolidator
PE platform	Medium (60–80%)	Medium (15–25%)	60–120 days	Sellers willing to hold rollover for the second sale; bigger deals
PE add-on	Higher (70–85%)	Low–Medium (10–20%)	45–90 days	Sellers folding into existing platform; faster process
Search fund / ETA	Medium (50–70%)	High (20–40%)	90–180 days	Legacy-conscious sellers wanting an owner-operator successor
Independent sponsor	Medium (55–75%)	Medium (15–30%)	60–120 days	Sellers OK with deal-by-deal capital and longer financing closes

FDA, FSMA, SQF, and BRC compliance

Food safety compliance is gating diligence in every F&B manufacturing transaction. FDA registration, FSMA preventive controls implementation, third-party food safety certifications (SQF, BRC, FSSC 22000), HACCP plans, allergen control programs, supplier verification programs, and recall plans all matter to buyer’s diligence assessment. Compliance gaps trigger 0.5-1.5x EBITDA discounts or kill deals.

FDA registration and FSMA requirements. FDA Food Facility Registration mandatory for all U.S. food manufacturers (renewable every 2 years). FSMA (Food Safety Modernization Act) preventive controls rule (21 CFR Part 117) requires Food Safety Plan with hazard analysis, preventive controls, monitoring, corrective actions, verification activities, recall plan. Foreign Supplier Verification Programs (FSVP) for imported ingredients. Sanitary Transportation Rule for food transportation.

SQF certification levels. Safe Quality Food (SQF) certification by SQFI (subsidiary of FMI). Level 1 (food safety fundamentals): table stakes for serious manufacturers. Level 2 (certified HACCP food safety plans): most common requirement for CPG supply chain. Level 3 (comprehensive food safety and quality management): premium positioning. SQF audits are unannounced for upper levels. Audit ratings: E (Excellent), G (Good), C (Compliant), Y (Conditional Pass), F (Fail). E and G ratings carry positive valuation implications.

BRC Global Standard for Food Safety. British Retail Consortium (BRC) Global Standard for Food Safety, version 9. Alternative to SQF, equally accepted by most CPG customers. Audit grades: AA, A, B, C, D. AA rating signals top-tier compliance. Annual audit cycle. Often required by international customers and customers with European market exposure.

FSSC 22000 and ISO 22000. FSSC 22000 (Food Safety System Certification) is GFSI (Global Food Safety Initiative) recognized, alternative to SQF/BRC. ISO 22000 alone is not GFSI-recognized but is commonly used as foundation for FSSC 22000. Customer-specific requirements drive certification choice; large CPG customers often accept multiple GFSI-recognized standards.

Co-manufacturing relationships and customer concentration

Co-manufacturing (co-man) relationships with major CPG brands are the highest-value asset in F&B manufacturing valuations. A co-manufacturer embedded with Procter & Gamble, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez, Unilever, or Nestlé earns premium pricing because the relationship represents irreplaceable invested capital. Switching costs are high (qualification process, formula transfer, scale-up costs, customer-specific quality requirements).

How co-man relationships are structured. Multi-year co-manufacturing agreements (typically 3-5 year terms with renewal options). Pricing structures: fixed cost-plus-margin or formula-based with ingredient pass-through. Volume commitments (minimum/maximum). Quality requirements with customer-specific specifications. Audit rights for customer quality teams. Confidentiality obligations restricting customer information disclosure. Termination provisions with transition support requirements.

Customer concentration thresholds. F&B manufacturing customer concentration is treated more leniently than general industrial when concentration is with named CPG brands on multi-year co-man agreements. Top customer 30-40% with named CPG and 5+ year relationship: moderate discount (0.25-0.5x EBITDA). 40-60% with strong agreement and tenure: 0.5-1x discount, often customer-retention earnout. Above 60%: 1-1.5x discount plus customer-specific protections.

Diversification through customer addition. Adding new co-man customers takes 12-24 months typically (qualification, scale-up, capacity allocation). Diversifying across multiple CPG customers reduces concentration risk meaningfully. Document customer relationship history, multi-year agreement status, and pipeline of potential new customer programs in CIM materials.

Fee structure	Math	Fee on $5M	% of deal
Standard Lehman	5/4/3/2/1 on first $1M / next $1M / etc.	$150K	3.0%
Modified Lehman (Double)	10/8/6/4/2	$300K	6.0%
Flat 8% commission	Common Main Street broker rate	$400K	8.0%
Flat 10% (sub-$2M deals)	Some brokers on smaller deals	$500K	10.0%
Buy-side partner	Buyer pays the partner; seller pays nothing	$0	0.0%

Recall history and food safety incident records

Recall history is gating diligence in F&B manufacturing transactions. Class I recalls (severe health hazard, potential for death or serious injury) significantly affect valuation. Class II recalls (moderate health risk) less severe but still concerning. Class III recalls (minimal health risk, mostly labeling issues) typically not deal-affecting if remediated. Recall causes (pathogen contamination, allergen mislabeling, foreign object, undeclared ingredients) drive different buyer concerns.

How buyers evaluate recall history. Recall count and frequency over 3-5 years. Root cause analysis documentation. Corrective action implementation evidence. Customer recovery (did customer relationships continue post-recall). FDA enforcement actions (Warning Letters, Untitled Letters, consent decrees) are particularly concerning. Litigation history related to recalls. Recall insurance coverage (separately from product liability).

Recall and contamination event valuation impact. Single Class I recall with proper remediation and continued customer relationships: 0.5-1x EBITDA discount, often diminishing over 24-36 months. Multiple Class I recalls within 3 years: 1-2x discount, sometimes deal-killing depending on customer reaction. FDA Warning Letter or consent decree: deal-killing without resolution. Pending litigation related to recalls: diligence stall, escrow/indemnification structure heavily affected.

Recall preparedness as valuation driver. Documented recall plans with regular testing exercises (mock recalls). Traceability systems (lot-level, ingredient-level, finished goods through distribution). Customer notification procedures. Insurance coverage (recall insurance, contaminated products insurance, product liability). Crisis communication protocols. Strong recall preparedness signals operational maturity even without recall history.

EBITDA add-backs and inventory accounting in F&B deals

F&B manufacturing businesses typically have $200K-$2M of legitimate add-backs to reported EBITDA at LMM size. Add-back categories include standard manufacturing add-backs plus F&B-specific items: one-time formula development for new customer programs, customer-specific tooling and packaging molds, one-time FDA registration fees, third-party certification costs, recall response costs (if non-recurring), discontinued product line losses.

Inventory accounting and ingredient cost volatility. F&B manufacturers carry meaningful ingredient inventory. LIFO accounting common for commodity ingredients with price volatility. FIFO common for shorter-shelf-life ingredients. Buyers’ QoE providers normalize inventory to current-cost replacement basis. LIFO reserves can swing reported EBITDA $100-500K depending on commodity price movements. Document inventory accounting methodology and LIFO reserve changes.

Promotional spending and slotting fee treatment. Branded F&B businesses spend significantly on trade promotion (slotting fees for retail listings, advertising, in-store demos, coupons). Buyers debate whether one-time customer launch promotional spending qualifies as add-back vs ongoing cost of doing business. Documentation of promotional spending by customer/event with separable launch vs maintenance categorization helps buyers accept legitimate one-time spending.

Capex normalization in F&B manufacturing. F&B manufacturing typically requires 4-7% of revenue in maintenance capex (line equipment refresh, packaging machinery, sanitation upgrades, allergen control infrastructure). Buyers normalize EBITDA by subtracting maintenance capex before applying multiples. Owners who don’t separate maintenance from growth capex see effective EBITDA understated. Document capex by category for last 5 years.

Sale process timeline for F&B manufacturing in 2026

A well-prepared F&B manufacturing sale runs 8-12 months from market launch to close at typical LMM size. Slightly longer than general manufacturing because of food safety diligence depth (third-party certification audits, FDA inspection records, recall history review), customer reference complexity (CPG customer confidentiality), and broader buyer outreach. Add 18-30 months on the front for proper preparation if compliance status, customer relationships, and financial reporting aren’t buyer-ready.

Months 1-2: positioning and outreach. Build CIM (35-60 pages with category, customer, and compliance detail). Position around right buyer archetype (F&B PE, CPG strategic, industrial PE with F&B experience, consumer PE for branded businesses). Outreach to 25-50 potential buyers. Sign NDAs — F&B NDAs typically restrict customer information disclosure given CPG confidentiality requirements. Narrow to 8-15 management meetings.

Months 2-4: management meetings and IOIs. In-person facility tours (always require physical visits given equipment, sanitation programs, capability demonstration). Customer reference calls late-stage with carefully managed CPG relationship preservation. Receive 4-8 indications of interest. Negotiate exclusivity. Sign LOI.

Months 4-7: diligence. Quality of Earnings ($75-150K, 6-8 weeks). Customer-level revenue verification and co-manufacturing agreement review. Food safety diligence: third-party audit reports (SQF, BRC, FSSC 22000), FDA inspection records, recall history, FDA Warning Letter status. Quality system audit. Insurance coverage review (product liability, recall insurance). Environmental Phase I (especially for older facilities). Customer reference calls with continuing-relationship preservation.

Months 7-12: documentation and close. Purchase agreement negotiation. Reps and warranties insurance procurement (typical for $5M+ EBITDA deals). Product liability and recall insurance tail. Employee notification 24-72 hours pre-close. Customer notification per co-manufacturing agreement requirements. FDA Food Facility Registration update. Third-party certification transfer to new ownership.

Common mistakes F&B manufacturing owners make in sale preparation

Mistake 1: under-investing in food safety certifications. Operating without SQF Level 2 or BRC certification when customer mix would support. Each certification adds 0.25-0.5x EBITDA and unlocks expanded CPG customer eligibility. The 12-18 month investment in certification typically returns 5-10x at exit.

Mistake 2: weak FSMA compliance documentation. FSMA (Food Safety Modernization Act) preventive controls implementation incomplete or undocumented. Buyer’s diligence finds compliance gaps, multiple compresses 0.25-0.75x. The 12-18 month investment in proper Food Safety Plan, Hazard Analysis, FSVP for imported ingredients pays back many times at exit.

Mistake 3: revealing CPG customer information improperly. Co-manufacturing agreements typically restrict customer information disclosure. Premature disclosure in marketing materials or to buyers who don’t advance to LOI can damage customer relationships or trigger contract violations. Use confidential profiles, restrictive NDAs, and staged disclosure.

Mistake 4: hiding recall history or FDA enforcement. Recall history and FDA enforcement actions are publicly available. Failure to disclose proactively triggers buyer trust issues that kill deals or compress pricing. Better to disclose proactively with documented remediation and customer recovery evidence.

Mistake 5: hiring a generalist business broker. Generalist brokers don’t have relationships with Wind Point Partners, Arsenal Capital Partners, Atlas Holdings, or CPG strategic M&A teams. They run a generic auction and the named F&B buyers never participate. Sub-optimal: 5-5.5x EBITDA from generalist bidders when 7-8x was available from F&B-savvy buyers.

Mistake 6: ignoring inventory accounting complexity. F&B inventory accounting (LIFO/FIFO, ingredient cost volatility, shelf-life write-offs) is complex and easy to mishandle. Aggressive inventory valuations or unclear LIFO reserve changes don’t survive QoE. Document inventory accounting methodology rigorously.

Earnout type	How it’s measured	Seller risk	When sellers should accept
Revenue-based	Top-line revenue over 12-24 months	Lower	Default seller preference; harder for buyer to manipulate than EBITDA
EBITDA-based	Adjusted EBITDA over the earnout period	High	Avoid if possible; buyer can manipulate via overhead allocations
Customer retention	% of named customers still buying at month 12, 24	Medium	Reasonable for sellers staying on through transition
Milestone-based	Specific deliverables (license transfer, geographic expansion, etc.)	Lower	Seller has control over the deliverable

Maximizing valuation: the 18-30 month preparation playbook

F&B manufacturing businesses benefit from longer preparation windows than general manufacturing because food safety certifications, customer relationship development, and FSMA compliance investment take time. Owners who prepare 18-30 months before going to market consistently see 30-50% better outcomes than reactive sellers.

Months 30-18: food safety and compliance foundation. FDA Food Facility Registration current. FSMA Food Safety Plan complete with hazard analysis and preventive controls. SQF Level 2 or 3 certification engagement. BRC Global Standard certification (if customer mix supports both). FSVP implementation for imported ingredients. Allergen control program documentation.

Months 18-12: customer relationships and category positioning. Pursue new co-manufacturing customers if currently concentrated. Document customer relationship history with specific CPG brands, multi-year agreement status, and program depth. Strengthen specialty/better-for-you positioning if applicable. Build private label customer pipeline if applicable.

Months 12-6: workforce and operational documentation. Document SOPs for sanitation, allergen control, foreign object prevention, recall procedures. Promote operations manager and quality manager from internal candidates. Build cross-training matrix for key positions. DOL apprenticeship program for skilled trades if applicable. Document quality system maturity with SPC, statistical process control, customer complaint trends.

Months 6-0: diligence package preparation. 36 months of tax returns, P&Ls, balance sheets, bank statements. Customer revenue indexed by named CPG customer and product line. Co-manufacturing agreements indexed by customer. Third-party audit reports (SQF, BRC, FSSC 22000) current. FDA inspection records. Recall history with remediation documentation. Insurance certificates current. Inventory accounting methodology documented. Capex by category for last 5 years.

Conclusion

Food and beverage manufacturing M&A in 2026 is more complex than general industrial because of food safety compliance, customer co-manufacturing relationships, and recall liability dynamics. EBITDA multiples of 5-8x reflect this complexity plus stable end-market demand. The owners who realize the top of that range are the ones who systematically built food safety credentials (SQF Level 3 or BRC AA-rated, FSMA preventive controls, FSVP for imports), embedded co-manufacturing relationships with named CPG brands, documented their quality systems, and went to market through buy-side partners with F&B-specific buyer relationships. The owners who anchor on general industrial comps, rely on generalist brokers who don’t know Wind Point Partners or Arsenal Capital Partners, and ignore SQF/BRC certification requirements typically realize 30-50% less than they could have. If you want to talk to someone who knows the F&B buyers personally instead of running an auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

What is a food and beverage manufacturing business worth in 2026?

F&B manufacturers sell for 5-8x EBITDA in 2026. By category: specialty/better-for-you brands 7-8x; co-manufacturers for CPG 5.5-7x; private label 5-6.5x; commodity F&B 4.5-6x. Direct-to-consumer brands have wide variance (4-7x) depending on customer acquisition cost economics. Customer mix and food safety certifications drive position within ranges.

Why do F&B manufacturers trade differently than general manufacturing?

Three structural factors: food safety compliance complexity (FDA, FSMA, SQF, BRC, HACCP), customer co-manufacturing relationship stickiness with major CPG brands, and recall liability exposure. Stable end-market demand offsets some complexity. Net: 5-8x EBITDA range with category, customer mix, and certification status as differentiators.

Who buys food and beverage manufacturing businesses?

Four archetypes: F&B-focused PE (Wind Point Partners, Arsenal Capital Partners), CPG strategic acquirers (P&G, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez, Unilever, Nestlé, Conagra, Campbell, Hormel, Tyson), industrial PE with F&B experience (Atlas Holdings, KPS, Audax, Sun Capital, H.I.G.), and consumer PE/growth equity (L Catterton, VMG Partners, TSG Consumer Partners) for branded businesses.

What food safety certifications matter most?

SQF (Safe Quality Food) Level 2 or 3 is the most common standard for CPG supply chain. BRC Global Standard for Food Safety is an alternative. FSSC 22000 (ISO 22000-based, GFSI-recognized) is another option. Each adds 0.25-0.5x EBITDA premium and unlocks expanded customer eligibility. Multiple GFSI-recognized certifications in place signal top-tier compliance.

What is FSMA and why does it matter for sale?

FSMA (Food Safety Modernization Act) preventive controls rule (21 CFR Part 117) requires Food Safety Plan with hazard analysis, preventive controls, monitoring, corrective actions, verification activities, and recall plan. FSMA implementation is mandatory; gaps trigger 0.25-0.75x EBITDA discount in diligence. FSVP (Foreign Supplier Verification Program) required for imported ingredients.

How do co-manufacturing relationships affect valuation?

Co-manufacturing relationships with major CPG brands (P&G, PepsiCo, Coca-Cola, Kraft Heinz, General Mills, Mondelez, Unilever, Nestlé) are the highest-value asset in F&B manufacturing valuations. Multi-year agreements with named CPG brands earn premium pricing. Customer relationship tenure (5+ years), program depth, and multi-customer relationships drive top-of-range multiples.

How does recall history affect a sale?

Class I recalls (severe health hazard) significantly affect valuation: 0.5-1x EBITDA discount per recall, diminishing over 24-36 months with proper remediation. Multiple Class I recalls in 3 years: 1-2x discount, sometimes deal-killing. FDA Warning Letter or consent decree: deal-killing without resolution. Class II/III recalls (moderate to minimal risk) less severe if remediated.

What customer concentration is acceptable in F&B manufacturing?

Customer concentration treated more leniently when concentration is with named CPG brands on multi-year co-manufacturing agreements. Top customer 30-40% with named CPG and 5+ year relationship: moderate discount (0.25-0.5x). 40-60%: 0.5-1x discount, often customer-retention earnout. Above 60%: 1-1.5x discount plus customer-specific protections.

How long does selling an F&B manufacturing business take?

8-12 months from market launch to close at typical LMM size. Slightly longer than general manufacturing because of food safety diligence depth, customer reference complexity (CPG confidentiality), and broader buyer outreach. Add 18-30 months on the front for proper preparation.

What add-backs survive QoE in F&B manufacturing?

Standard add-backs (owner above-market comp, one-time legal, family member without operational role) plus F&B-specific: one-time formula development for new customer programs, customer-specific tooling/packaging molds, third-party certification investment costs, one-time recall response costs (if non-recurring), discontinued product line losses, one-time FDA registration costs.

Should I run a broker auction or use a buy-side partner?

For F&B manufacturing $2M+ EBITDA, the named F&B PE platforms (Wind Point Partners, Arsenal Capital Partners), industrial PE with F&B experience (Atlas Holdings, KPS Capital Partners), and CPG strategic M&A teams drive top-of-range pricing. Generalist business brokers typically don’t have these relationships. Buy-side partners with F&B-specific buyer networks consistently deliver 1-2x EBITDA better outcomes than generalist auctions.

Asset sale or stock sale for F&B manufacturing?

Most F&B manufacturing transactions are asset sales for buyer liability protection (especially for product liability and recall exposure) and depreciation step-up. Stock sales (or 338(h)(10) elections) common at $10M+ EBITDA when co-manufacturing agreements, FDA registrations, and customer qualifications make stock structure cleaner operationally.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge 8-12% of the deal (often $300K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers including 38 manufacturing-focused capital partners — F&B PE, CPG strategics, industrial PE with F&B experience, consumer PE, and family offices — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-120 days from intro to close) because we already know who the right buyer is rather than running an auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. https://www.fda.gov/food/guidance-regulation-food-and-dietary-supplements/food-safety-modernization-act-fsma
2. https://www.sqfi.com/
3. https://www.brcgs.com/our-standards/food-safety/
4. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000080424&type=10-K
5. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000077476&type=10-K
6. https://www.windpointpartners.com/portfolio/
7. https://www.arsenalcapital.com/portfolio/
8. https://mygfsi.com/